Erratum to: 'Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism - the J-EINSTEIN DVT and PE program'.

Yamada, Norikazu; Hirayama, Atsushi; Maeda, Hideaki; Sakagami, Satoru; Shikata, Hiroo; Prins, Martin H; Lensing, Anthonie W A; Kato, Masaharu; Onuma, Junichi; Miyamoto, Yuki; Iekushi, Kazuma; Kajikawa, Mariko.

Afiliação

Yamada N; Department of Cardiology and Nephrology, Mie University Graduate School of Medicine, Mie, Japan.
Hirayama A; Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Maeda H; Division of Cardiovascular, Respiratory and general surgery, Nihon University School of Medicine, Tokyo, Japan.
Sakagami S; Department of Cardiology, National Hospital Organization, Kanazawa Medical Center, Kanazawa, Japan.
Shikata H; Department of Cardiovascular Surgery, Kanazawa Medical University, Ishikawa, Japan.
Prins MH; Maastricht University Medical Center, Maastricht, The Netherlands.
Lensing AW; Bayer HealthCare Pharmaceuticals, Wuppertal, Germany.
Kato M; Bayer Yakuhin Ltd, Osaka, Japan.
Onuma J; Bayer Yakuhin Ltd, Osaka, Japan.
Miyamoto Y; Bayer Yakuhin Ltd, Osaka, Japan.
Iekushi K; Bayer Yakuhin Ltd, Osaka, Japan.
Kajikawa M; Bayer Yakuhin Ltd, Osaka, Japan.

Thromb J ; 14: 11, 2016.

Article em En | MEDLINE | ID: mdl-27222638

ABSTRACT

[This corrects the article DOI 10.1186/s12959-015-0035-3.].

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2016 Tipo de documento: Article